About Nucleus Laboratories
Nucleus Laboratories was a Healthcare company based in Mumbai (India). It provides comprehensive quality management solutions for the biopharma sector. It operates on a B2B model. Its Indian entity Nucleus Laboratories (India) Limted reported revenue of ₹2.48 Cr. The company is recorded as dissolved. Its focus areas include Biopharmaceuticals, Quality Management and Service Solutions.
Company details
Nucleus Laboratories provides comprehensive quality management solutions for the biopharma sector, focusing on providing healthcare solutions, biopharmaceuticals, ensuring quality management, and service solutions. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website nucleuslaboratories.com
- Legal Name Nucleus Laboratories (India) Limted
- Date of Incorporation 07 Dec, 1999
- Jurisdiction Lucknow, Uttar Pradesh, India
- Annual Revenue₹2.48 Cr
FY 2020 · -16% YoY
- Net Loss-₹18.5 Lakh
FY 2020 · -7% margin
- EBITDA-₹23.8 Lakh
FY 2020 · -10% margin
Associated legal entities of Nucleus Laboratories
Nucleus Laboratories operates through Nucleus Laboratories (India) Limted (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2020) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nucleus Laboratories (India) Limted CIN U24231UP1999PLC024944 | Active | 07 Dec 1999 | Lucknow, Uttar Pradesh | ₹2.5 Cr | 5 | View details |
Board of directors of Nucleus Laboratories (India) Limted (Nucleus Laboratories)
Nucleus Laboratories (India) Limted is the primary company behind Nucleus Laboratories. The board of Nucleus Laboratories (India) Limted currently have 5 directors; the longest-serving is Ashish Kumar Singh, appointed in 2000. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashish Kumar Singh DIN 01189756 | Director | 27 Nov 2000 | 25 yrs 11 mo | Nucleus Laboratories (India) Limted |
| Gyan Prakash Shrivastava DIN 08545629 | Director | 07 Mar 2022 | 4 yrs 7 mo | Nucleus Laboratories (India) Limted |
| Chandana Shrivastava DIN 09523772 | Director | 07 Mar 2022 | 4 yrs 7 mo | Nucleus Laboratories (India) Limted |
| Debashish Saha DIN 10160104 | Director | 01 Jun 2023 | 3 yrs 5 mo | Nucleus Laboratories (India) Limted |
| Himani Shukla DIN 11219612 | Director | 01 Aug 2025 | 1 yr 3 mo | Nucleus Laboratories (India) Limted |
Financials of Nucleus Laboratories
Figures of Nucleus Laboratories (India) Limted, the primary company behind Nucleus Laboratories, for FY 2020. Revenue was ₹2.48 Cr (-16% year on year). Net loss was -₹18.5 Lakh (-7% margin). EBITDA was -₹23.8 Lakh (-10% margin). Revenue has grown at a compounded annual rate of +140% over three years and +57% over five years.
- ₹2.48 CrRevenue · FY 2020 · -16% YoY
- -₹18.5 LakhNet loss · -7% margin
- -₹23.8 LakhEBITDA · -10% margin
- ₹1.00 CrPaid-up capital
- +140%Revenue CAGR, 3 years
- +57%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nucleus Laboratories (India) Limted are on its company page.
Detailed financial statements for Nucleus Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Nucleus Laboratories (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nucleus Laboratories
Nucleus Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Nucleus Laboratories, Nucleus Laboratories (India) Limted, reported revenue of ₹2.48 Cr for FY 2020, down 16% year on year.
Nucleus Laboratories provides comprehensive quality management solutions for the biopharma sector, focusing on providing healthcare solutions, biopharmaceuticals, ensuring quality management, and service solutions. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Nucleus Laboratories operates through Nucleus Laboratories (India) Limted.
The legal entities of Nucleus Laboratories currently have 5 directors, including Ashish Kumar Singh, Gyan Prakash Shrivastava, Chandana Shrivastava and others.